Abstract
Transformation of fibroblasts by V-SEA involves activation of the ERK and phosphatidylinositol 3-kinase (PI3K) pathways. Effector proteins that are key mediators of the ERK and PI3K pathways, namely Grb2, the tyrosine phosphatase, SHP2 and PI3K, interact with the two phosphotyrosines found in the bidentate motif in the carboxy-terminal region of V-SEA. Genetic analysis demonstrated that while Y557 was a primary binding site and thus activator of the PI3K-Akt pathway, Y564 also contributed to the activation of this pathway. Y564 was located within a Grb2-binding motif, this raised the possibility that a protein that associated with Grb2 might be important for this PI3K activation. The scaffolding proteins Gab1 and/or Gab2 were candidates for this role. In this report, we demonstrate that V-SEA preferentially interacts with Gab2. Furthermore by using Gab2 null fibroblasts, we demonstrate that Gab2 is essential for fibroblast transformation by V-SEA. Using mutant forms of Gab2, we show that activation of the PI3K-Akt pathway via Gab2 is required for V-SEA-induced transformation. However, efficient fibroblast transformation also requires the SHP2 interaction site on Gab2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agazie Y, Ischenko I and Hayman M . (2002). Oncogene, 21, 697–707.
Aoki M, Blazek E and Vogt PK . (2001). Proc. Natl. Acad. Sci. USA, 98, 136–141.
Bardelli A, Longati P, Gramaglia D, Stella MC and Comoglio PM . (1997). Oncogene, 15, 3103–3111.
Cantley LC . (2002). Science, 296, 1655–1657.
Crowe AJ and Hayman MJ . (1991). J. Virol., 65, 2533–2538.
Crowe AJ and Hayman MJ . (1993a). Cell. Growth Differ., 4, 403–410.
Crowe AJ and Hayman MJ . (1993b). Oncogene, 8, 181–189.
Gu H, Maeda H, Moon JJ, Lord JD, Yoakim M and Nelson BH Neel BG . (2000). Mol. Cell. Biol., 20, 7109–7120.
Gu H, Pratt JC, Burakoff and SJ Neel BG . (1998). Mol. Cell., 2, 729–740.
Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP and Neel BG . (2001). Nature, 412, 186–190.
Ingham RJ, Holgado-Madruga M, Siu C, Wong AJ and Gold MR . (1998). J. Biol. Chem., 273, 30630–30637.
Itoh M, Yoshida Y, Nishida K, Narimatsu M, Hibi M and Hirano T . (2000). Mol. Cell. Biol., 20, 3695–3704.
Liu Y, Jenkins B, Shin JL and Rohrschneider LR . (2001). Mol. Cell. Biol., 21, 3047–3056.
Liu Y and Rohrschneider LR . (2002). FEBS Lett., 515, 1–7.
Lock LS, Maroun CR, Naujokas MA and Park M . (2002). Mol. Biol. Cell., 13, 2132–2146.
Morimoto AM and Hayman MJ . (1994). J. Virol., 68, 1837–1842.
Nguyen L, Holgado-Madruga M, Maroun C, Fixman ED, Kamikura D, Fournier T, Charest A, Tremblay ML, Wong AJ and Park M . (1997). J. Biol. Chem., 272, 20811–20819.
Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J and Lax I . (2001). Proc. Natl. Acad. Sci. USA, 98, 6074–6079.
Park CY and Hayman MJ . (1999). J. Biol. Chem., 274, 7583–7590.
Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G and Comoglio PM . (1994). Cell, 77, 261–271.
Pratt JC, Igras VE, Maeda H, Baksh S, Gelfand EW, Burakoff SJ, Neel BG and Gu H . (2000). J. Immunol., 165, 4158–4163.
Ronsin C, Muscatelli F, Mattei MG and Breathnach R . (1993). Oncogene, 8, 1195–1202.
Sachs M, Brohmann H, Zechner D, Muller T, Hulsken J, Walther I, Schaeper U, Birchmeier C and Birchmeier W . (2000). J. Cell. Biol., 150, 1375–1384.
Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K, Gesbert F, Iwasaki H, Li S, Van Etten RA, Gu H, Griffin JD and Neel BG . (2002). Cancer Cell., 1, 479–492.
Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes B and Birchmeier W . (2000). J. Cell. Biol., 149, 1419–1432.
Seiffert M, Custodio JM, Wolf I, Harkey M, Liu Y, Blattman JN, Greenberg PD and Rohrschneider LR . (2003). Mol. Cell. Biol., 23, 2415–2424.
Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW . (1997). Cell, 88, 593–602.
Smith DR, Vogt PK and Hayman MJ . (1989). Proc. Natl. Acad. Sci. USA, 86, 5291–5295.
Suda T, Iwama A, Hashiyama M, Sakano S and Ohno M . (1997). Leukemia, 11 (Suppl 3), 451–453.
Vogt PK . (2001). Trend Mol. Med., 7, 482–484.
Wahl RC, Hsu RY, Huff JL, Jelinek MA, Chen K, Courchesne P, Patterson SD, Parsons JT and Welcher AA . (1999). J. Biol. Chem., 274, 26361–26368.
Wang MH, Iwama A, Skeel A, Suda T and Leonard EJ . (1995). Proc. Natl. Acad. Sci. USA, 92, 3933–3937.
Wang MH, Ronsin C, Gesnel MC, Coupey L, Skeel A, Leonard EJ and Breathnach R . (1994). Science, 266, 117–119.
Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J and Birchmeier W . (1996). Nature, 384, 173–176.
Zhu H, Naujokas MA, Fixman ED, Torossian K and Park M . (1994). J. Biol. Chem., 269, 29943–29948.
Acknowledgements
We thank Drs D Bar-Sagi, P Hearing, D Morrison, B Neel and L Rohrschneider for kindly providing the reagents that made this work possible. We also thank the members of our laboratory for their helpful advice and constructive criticisms. This work was supported by NIH Public Service Grant CA28146 and the Carol Baldwin Breast Cancer Award to MJH, and American Association of Cancer Research-Susan G Komen Breast Cancer Foundation Career Development Award to HG.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ischenko, I., Petrenko, O., Gu, H. et al. Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase. Oncogene 22, 6311–6318 (2003). https://doi.org/10.1038/sj.onc.1206742
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206742
Keywords
This article is cited by
-
Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma
British Journal of Cancer (2013)
-
Gab2
AfCS-Nature Molecule Pages (2010)
-
Focal amplification and oncogene dependency of GAB2 in breast cancer
Oncogene (2010)
-
Function, regulation and pathological roles of the Gab/DOS docking proteins
Cell Communication and Signaling (2009)
-
Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance
Journal of Cancer Research and Clinical Oncology (2009)